AI assistant
Glimpse Group, Inc. — Director's Dealing 2024
Jun 4, 2024
34791_dirs_2024-06-04_2db2bf0a-6647-434a-b893-94a0a3fbf1be.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Glimpse Group, Inc. (VRAR)
CIK: 0001854445
Period of Report: 2024-04-29
Reporting Person: Elkeles Tamar (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-04-29 | Stock Option (Right to Purchase) | $2.50 | A | 20000 | Acquired | 2034-04-29 | Common Stock (20000) | Direct |
Footnotes
F1: On April 27, 2024, the board of directors (the "Board") of The Glimpse Group, Inc. (the "Company"), appointed Dr. Elkeles to the Board, and in connection therewith, agreed to grant to Dr Elkeles, under the Company's 2016 Incentive Plan, options ("Options") to purchase an aggregate of 20,000 shares of the Company's common stock, as compensation for her service on the Board for the remainder of the calendar year ending December 31, 2024. The Options vest in monthly increments beginning April 29, 2024 through December 31, 2024, and are exercisable for $2.50 per share. The Options are deemed exercisable when, and to the extent, they become vested.